290 related articles for article (PubMed ID: 33462873)
21. High mobility group box-1-toll-like receptor 4-phosphatidylinositol 3-kinase/protein kinase B-mediated generation of matrix metalloproteinase-9 in the dorsal root ganglion promotes chemotherapy-induced peripheral neuropathy.
Gu H; Wang C; Li J; Yang Y; Sun W; Jiang C; Li Y; Ni M; Liu WT; Cheng Z; Hu L
Int J Cancer; 2020 May; 146(10):2810-2821. PubMed ID: 31465111
[TBL] [Abstract][Full Text] [Related]
22. Carvedilol prevents functional deficits in peripheral nerve mitochondria of rats with oxaliplatin-evoked painful peripheral neuropathy.
Areti A; Komirishetty P; Kumar A
Toxicol Appl Pharmacol; 2017 May; 322():97-103. PubMed ID: 28286117
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.
Kerckhove N; Busserolles J; Stanbury T; Pereira B; Plence V; Bonnetain F; Krakowski I; Eschalier A; Pezet D; Balayssac D
BMJ Open; 2019 Jun; 9(6):e027770. PubMed ID: 31182448
[TBL] [Abstract][Full Text] [Related]
24. A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice.
Calls A; Torres-Espin A; Tormo M; Martínez-Escardó L; Bonet N; Casals F; Navarro X; Yuste VJ; Udina E; Bruna J
Ann Clin Transl Neurol; 2022 Dec; 9(12):1985-1998. PubMed ID: 36369764
[TBL] [Abstract][Full Text] [Related]
25. Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation.
Di Cesare Mannelli L; Pacini A; Matera C; Zanardelli M; Mello T; De Amici M; Dallanoce C; Ghelardini C
Neuropharmacology; 2014 Apr; 79():37-48. PubMed ID: 24225197
[TBL] [Abstract][Full Text] [Related]
26. Neuronal drug transporters in platinum drugs-induced peripheral neurotoxicity.
Cavaletti G; Ceresa C; Nicolini G; Marmiroli P
Anticancer Res; 2014 Jan; 34(1):483-6. PubMed ID: 24403505
[TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment.
Kang L; Tian Y; Xu S; Chen H
J Neurol; 2021 Sep; 268(9):3269-3282. PubMed ID: 32474658
[TBL] [Abstract][Full Text] [Related]
28. Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons.
Liu JJ; Kim Y; Yan F; Ding Q; Ip V; Jong NN; Mercer JF; McKeage MJ
Biochem Pharmacol; 2013 Jan; 85(2):207-15. PubMed ID: 23123662
[TBL] [Abstract][Full Text] [Related]
29. Prolonged oxaliplatin exposure alters intracellular calcium signaling: a new mechanism to explain oxaliplatin-associated peripheral neuropathy.
Schulze C; McGowan M; Jordt SE; Ehrlich BE
Clin Colorectal Cancer; 2011 Jun; 10(2):126-33. PubMed ID: 21859566
[TBL] [Abstract][Full Text] [Related]
30. Endothelial Glycocalyx in the Peripheral Capillaries is Injured Under Oxaliplatin-Induced Neuropathy.
Kuroda T; Suzuki A; Okada H; Shimizu M; Watanabe D; Suzuki K; Mori K; Ohmura K; Niwa A; Imaizumi Y; Matsuo M; Ichihashi K; Okubo T; Taniguchi T; Kanayma T; Kobayashi R; Sugie S; Hara A; Tomita H
J Pain; 2024 Jun; 25(6):104462. PubMed ID: 38211844
[TBL] [Abstract][Full Text] [Related]
31. Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity.
Nepal MR; Taheri H; Li Y; Talebi Z; Uddin ME; Jin Y; DiGiacomo DF; Gibson AA; Lustberg MB; Hu S; Sparreboom A
Cancer Res Commun; 2022 Nov; 2(11):1334-1343. PubMed ID: 36506732
[TBL] [Abstract][Full Text] [Related]
32. Mitotherapy prevents peripheral neuropathy induced by oxaliplatin in mice.
Maia JRLCB; Machado LKA; Fernandes GG; Vitorino LC; Antônio LS; Araújo SMB; Colodeti LC; Fontes-Dantas FL; Zeidler JD; Saraiva GN; Da Poian AT; Figueiredo CP; Passos GF; da Costa R
Neuropharmacology; 2024 Mar; 245():109828. PubMed ID: 38158014
[TBL] [Abstract][Full Text] [Related]
33. Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.
Chen SJ; Chen LH; Yeh YM; Lin CK; Lin PC; Huang HW; Shen MR; Lin BW; Lee JC; Lee CC; Lee YF; Chiang HC; Chang JY
Theranostics; 2021; 11(10):4672-4687. PubMed ID: 33754020
[No Abstract] [Full Text] [Related]
34. The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents.
Perde-Schrepler M; Fischer-Fodor E; Virag P; Brie I; Cenariu M; Pop C; Valcan A; Gurzau E; Maniu A
Hear Res; 2020 Mar; 388():107893. PubMed ID: 32006874
[TBL] [Abstract][Full Text] [Related]
35. Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach.
Zanardelli M; Micheli L; Cinci L; Failli P; Ghelardini C; Di Cesare Mannelli L
PLoS One; 2014; 9(7):e102758. PubMed ID: 25036594
[TBL] [Abstract][Full Text] [Related]
36. Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial.
Balayssac D; Ferrier J; Pereira B; Gillet B; Pétorin C; Vein J; Libert F; Eschalier A; Pezet D
BMJ Open; 2015 Apr; 5(4):e007479. PubMed ID: 25833669
[TBL] [Abstract][Full Text] [Related]
37. Development of hepatic impairment aggravates chemotherapy-induced peripheral neuropathy following oxaliplatin treatment: Evidence from clinical and preclinical studies.
Miyamoto T; Domoto R; Sekiguchi F; Kamaguchi R; Nishimura R; Matsuno M; Tsubota M; Fujitani M; Hatanaka S; Koizumi Y; Wang D; Nishibori M; Kawabata A
J Pharmacol Sci; 2022 Mar; 148(3):315-325. PubMed ID: 35177211
[TBL] [Abstract][Full Text] [Related]
38. Oxaliplatin Regulates Chemotherapy Induced Peripheral Neuropathic Pain in the Dorsal Horn and Dorsal Root Ganglion via the Calcineurin/NFAT Pathway.
Huang W; Huang J; Jiang Y; Huang X; Xing W; He Y; Ouyang H
Anticancer Agents Med Chem; 2018; 18(8):1197-1207. PubMed ID: 29793414
[TBL] [Abstract][Full Text] [Related]
39. Involvement of substance P in peripheral neuropathy induced by paclitaxel but not oxaliplatin.
Tatsushima Y; Egashira N; Kawashiri T; Mihara Y; Yano T; Mishima K; Oishi R
J Pharmacol Exp Ther; 2011 Apr; 337(1):226-35. PubMed ID: 21233199
[TBL] [Abstract][Full Text] [Related]
40. Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors.
Potenzieri A; Riva B; Rigolio R; Chiorazzi A; Pozzi E; Ballarini E; Cavaletti G; Genazzani AA
Pain; 2020 Feb; 161(2):405-415. PubMed ID: 31634341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
